Eye disorder and Immobile
Summary:
Immobile is found among people with Eye disorder, especially for people who are female, 60+ old.
The study analyzes which people have Immobile with Eye disorder. It is created by eHealthMe based on reports of 50 people who have Eye disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Eye disorder?
Eye disorder is found to be associated with 1,351 drugs and 1,453 conditions by eHealthMe. Check the latest studies of Eye disorder.
What is Immobile?
Immobile (not moving) is found to be associated with 465 drugs and 585 conditions by eHealthMe. Check the latest studies of Immobile.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
50 people who have Eye Disorder and Immobile are studied.

Gender of people who have Eye Disorder and experienced Immobile *:
- female: 100 %
- male: 0.0 %
Age of people who have Eye Disorder and experienced Immobile *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 30.95 %
- 60+: 69.05 %
Common co-existing conditions for these people *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 50 people, 100.00%
- Thyroid Diseases: 47 people, 94.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.00%
Common drugs taken by these people *:
- Synthroid: 50 people, 100.00%
- Restasis: 50 people, 100.00%
- Xeljanz: 48 people, 96.00%
- Humira: 48 people, 96.00%
- Enbrel: 48 people, 96.00%
- Actemra: 48 people, 96.00%
- Rituxan: 39 people, 78.00%
- Sulfasalazine: 1 person, 2.00%
- Prednisone: 1 person, 2.00%
- Multivitamin: 1 person, 2.00%
Common symptoms for these people *:
- Malignant Melanoma (skin cancer rises from melancytes): 50 people, 100.00%
- Herpes Zoster: 50 people, 100.00%
- Injury: 48 people, 96.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 48 people, 96.00%
- Emotional Disorder: 48 people, 96.00%
- Drug Ineffective: 48 people, 96.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 47 people, 94.00%
- Therapeutic Response Decreased (less preventive response): 1 person, 2.00%
- Drug Intolerance (drug sensitivity): 1 person, 2.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Immobile?
- Check whether Immobile is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Eye disorder (40,666 reports)
- Immobile (5,336 reports)
All the drugs that are associated with Immobile:
- Immobile (465 drugs)
All the conditions that are associated with Immobile:
- Immobile (585 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Immobile and Eye disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Back Disorder and Drug Abuse And Dependence - 2 seconds ago
- Could Wellbutrin Xl cause Oesophageal Pain? - 5 seconds ago
- Could Fish Oil cause Haemolysis? - 7 seconds ago
- Could Cardura cause Asthma? - 7 seconds ago
- Could Pomalidomide cause Weight Decreased? - 8 seconds ago
- Could Cardizem cause Bruxism? - 8 seconds ago
- Could Fish Oil cause Blood Viscosity Increased? - 9 seconds ago
- Could Meclizine cause Bronchiectasis? - 13 seconds ago
- Could Cardizem cause Septic Shock? - 13 seconds ago
- Could Metformin Hydrochloride cause Tenderness? - 15 seconds ago